Royal Philips


Litigation uncertainty no longer an overhang; Q1 profitability beat

29/04/24 -"Philips’ Q1 24 profits exceeded the company-compiled consensus. The low-single-digit sales growth was supported by D&T and PH, however, CC reported a modest decline. Nonetheless, productivity ..."

Pages
63
Language
English
Published on
29/04/24
You may also be interested by these reports :
15/05/24
Bastide reported stronger organic growth in Q3 than in the previous two quarters. The group is currently spinning off two Swiss subsidiaries, which ...

15/05/24
Orpea published overall good-looking organic revenue in the Q1, primarily led by improvements in the international performance while its activities ...

15/05/24
Coloplast reported softer than expected Q2 24 figures. However, with healthy organic growth, the miss reflected FX headwinds, and, hence, was not ...

14/05/24
We have maintained our assumptions based on the company’s planned €300m recap to be completed by the end of this year, but with an expected ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO